|
|
 |
|
FOLD: Amicus Therapeutics Inc - Stock News |
Enter Ticker:
|
|
| Nov 12, 2009 |
Amicus Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009 |
| Nov 03, 2009 |
Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors |
| Nov 02, 2009 |
Phase Forward to Host Eighth Annual International Users Conference, November 3-5, Boston |
| Oct 30, 2009 |
BUYINS.NET: Amicus Therapeutics (FOLD) Down After BUYINS.NET Report Predicted Weakness After Earnings |
| Oct 29, 2009 |
Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates |
| Oct 27, 2009 |
BUYINS.NET: CACB, FOLD, NOVA, LB, ACU Expected To Be Lower After Earnings Releases on Thursday |
| Oct 26, 2009 |
Amicus Therapeutics Announces Third Quarter 2009 Financial Results Release Date |
| Oct 20, 2009 |
Amicus Therapeutics Down 51.7% Since SmarTrend's Sell Recommendation |
| Oct 05, 2009 |
Today's Big Losers: SGEN, TMS, SCLN, FOLD |
| Oct 05, 2009 |
BUYINS.NET: Amicus Therapeutics (FOLD) Daily Short Sale Trading Volume Through 10-2-09 |
| Oct 05, 2009 |
Amicus Theraputics (FOLD) Downgrade Alert, Watch for 5.3% Technical Downtrend Continuation |
| Oct 05, 2009 |
Analyst Downgrades for October 5th |
| Oct 05, 2009 |
Analyst Downgrades for 10/5/2009... Advanced Micro (NYSE:AMD) downgraded to Market Perform from Outperform at FBR Capital... AMAG Pharma (NASDAQ:AMAG) downgraded to Hold from Buy at Jefferies... Amicus Theraputics (NASDAQ:FOLD) downgraded to Neutral from Overweight at JP Morgan... Fifth Third Bancorp (NASDAQ:FITB) downgraded to Buy from Conviction Buy at Goldman... Polycom (NASDAQ:PLCM) downgraded to Market Perform at Wells Fargo... ResMed (NYSE:RMD) downgraded to Hold, $48 target, at Canaccord... TiVo (NASDAQ:TIVO) initiated as Neutral at JPMorgan... Valero (NYSE:VLO) downgraded to Sell at Deutsche Bank... |
| Oct 03, 2009 |
Amicus Therapeutics Reported Disappointing Results For Gaucher Drug (FOLD) |
| Oct 02, 2009 |
Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease |
| |
| ZACKS COMMENTARY FOR FOLD |
|
|
|
Sponsored Links 
0.11